Winebrenner Capital Management’s Pacer Aristotle Pacific Floating Rate High Income ETF FLRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.86M Sell
104,130
-14,594
-12% -$682K 2.96% 6
2026
Q1
$5.5M Sell
118,724
-3,769
-3% -$176K 3.53% 4
2025
Q4
$5.77M Buy
122,493
+3,654
+3% +$173K 3.85% 4
2025
Q3
$5.63M Buy
118,839
+14,322
+14% +$680K 4.05% 3
2025
Q2
$4.98M Buy
104,517
+17,940
+21% +$842K 4.01% 4
2025
Q1
$4.08M Buy
86,577
+27,426
+46% +$1.3M 3.68% 5
2024
Q4
$2.81M Buy
+59,151
New +$2.82M 2.17% 8

Other funds holding FLRT

Winebrenner Capital Management's FLRT Position: Q2 2026 in Review

Winebrenner Capital Management reduced its Pacer Aristotle Pacific Floating Rate High Income ETF (FLRT) stake by 12% in Q2 2026, selling an estimated $682K and leaving 104,130 shares worth $4.86M. The position accounts for 2.96% of the portfolio, ranked #6.

Winebrenner Capital Management first reported a position in FLRT in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.77M in Q4 2025. 23 funds tracked by Wall St. Rank hold FLRT as of Q2 2026.

  • Winebrenner Capital Management held 104,130 shares of Pacer Aristotle Pacific Floating Rate High Income ETF worth $4.86M as of Q2 2026.
  • Winebrenner Capital Management sold 14,594 Pacer Aristotle Pacific Floating Rate High Income ETF shares in Q2 2026, an estimated $682K.
  • Pacer Aristotle Pacific Floating Rate High Income ETF made up 2.96% of Winebrenner Capital Management's portfolio in Q2 2026, its #6 holding.
  • Winebrenner Capital Management first reported a position in Pacer Aristotle Pacific Floating Rate High Income ETF in Q4 2024 and has held it in 7 quarters since.
  • Winebrenner Capital Management's Pacer Aristotle Pacific Floating Rate High Income ETF position peaked at $5.77M in Q4 2025.
  • 23 funds tracked by Wall St. Rank held Pacer Aristotle Pacific Floating Rate High Income ETF as of Q2 2026.

Based on Winebrenner Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.